期刊文献+

糖尿病合并高脂血症的临床降脂治疗80例 被引量:5

Analysis of the clinical lipid-lowering treatment of diabetes mellitus with hyperlipidemia
下载PDF
导出
摘要 目的观察阿托伐他汀钙对2型糖尿病合并高脂血症患者的疗效。方法选取80例2型糖尿病合并高脂血症患者应用立普妥治疗1个月,观察血脂变化情况。结果立普妥纠正糖尿病患者的血脂异常总有效率为100%,以降低总胆固醇、低密度胆固醇水平为主,同时也降低甘油三酯、升高高密度胆固醇水平。结论立普妥能迅速有效调节2型糖尿病伴高脂血症患者的血脂异常,降低心脑血管卒中的危险性。 Objective To observe the treatment effect of Atorvastatin Calcium on type 2 diabetes mellitus(T2DM)patients with hyperlipemia.Methods 80 T2DM patients with hyperlipemia were selected to be cured by Lipitor for a month,and observed their lipid changes.Results The total effective rate was 100% by Lipitor correctd the dyslipidemia of the diabetes mellitus patients.Lipitor mainly reduced total cholesterol and low density cholesterol level,and it also lowered triglyceride and increased high density cholesterol level.Conclusion Lipitor can quickly and effectively regulate the dyslipidemia of T2DM patients with hyperlipemia,and reduce the risk of cardiovascular stroke.
作者 李鹏翔
出处 《广州医药》 2011年第2期33-35,共3页 Guangzhou Medical Journal
关键词 2型糖尿病 高脂血症 阿托伐他汀钙 Type 2 diabetes mellitus Hyperlipidemia Atorvastatin Calcium
  • 相关文献

参考文献5

二级参考文献20

  • 1李莹,陈志红,周北凡,李义和,武阳丰,刘小清,赵连成,麦劲壮,杨军,石美玲,田秀珍,关渭全,于学海,陈磊.血脂和脂蛋白水平对我国中年人群缺血性心血管病事件的预测作用[J].中华心血管病杂志,2004,32(7):643-647. 被引量:326
  • 2陈葵,徐忠宝,薛启,李虹伟,江明庆.脑卒中患者胰岛素抵抗状态分析[J].友谊医刊,1998,21(2):45-47. 被引量:32
  • 3HUDY ZHAOMZ.Coronary heart disease is modem interfere with tactics progressing newly .中国医刊,2004,39(3):4-6.
  • 4LIANGWJ XIANHG CHENL etal.At high risk of cardiovascular events in patients with postprandial changes of creactive protein concentration and the effect of simvastatin analysis .中国实用内科杂志,2005,25(7):598-599.
  • 5Meisinger C,Doring A,Thorand B,et al.Body fat distribution and risk of type 2 diabetes in the general population:are there differences between men and women? The MONICA/KORA Augsburg cohort study[J].Am J Clin Nutr,2006,84(3):483-489.
  • 6Ito MK,Talbert RL,Tsimikas S.Statin-associated pleiotropy:possible neneficial effects beyond cholesterol reduction[J].Pharmacotherapy,2006,26(7Pt2):85s-97s.
  • 7Patti G,Nusca A,Chello M,et al.Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronany intervention[J].Am J Cardiol,2008,101(3):279-285.
  • 8Ichiki T,Takeda K,Tokunou T,et al.Downregulation of angiotensin Ⅱ type 1 receptor by hydrophobic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in vascular smooth muscle cells[J].Arterioscler Thromb Vasc Biol,2001,21(12):1896-1901.
  • 9Chello M,Goffredo C,Patti G,et al.Effects of atorvastatin on arterial endothelial function in coronary bypass surgery[J].Eur J Cardiothorac Surg,2005,28(6):805-810.
  • 10Mason JC,Ahmed Z,Mankoff R,et al.Statin-induced expression of decay-accelerating factor protects vascular endothelial against complement-mediated injury[J].Circ Res,2002,91(8):696-703.

共引文献38

同被引文献39

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部